20 reports

Interferon Beta-##A Sales, Price Analysis, & Sales Forecast - 2017 ##.

  • Biological Therapy
  • Interferon
  • World
  • Demand

Interferon Gamma-##B Sales, Price Analysis, & Sales Forecast - 2017 ##.

  • Biological Therapy
  • Interferon
  • World
  • Demand

Interferon Alfa-##B Sales, Price Analysis, & Sales Forecast - 2017 ##.

  • Biological Therapy
  • Interferon
  • World
  • Demand

Interferon Beta-##B Sales, Price Analysis, & Sales Forecast - 2017 ##.

  • Biological Therapy
  • Interferon
  • World
  • Demand

Interferon is mainly divided into ordinary interferon and long-acting interferon.

  • Biological Therapy
  • Hepatitis
  • Interferon
  • China
  • Market Size
  • Interferon
  • Interferon

This study focuses on China’s Pneumonia Treatment Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s...

  • Interferon
  • China
  • Demand
  • Harbin Pharmaceutical Group
  • North China Pharmaceutical Group Corp.
  • Interferon Major Producer and Their Market Share
  • Interferon Sales Volume (Million Yuan)

This study focuses on China’s Skin Cancer Treatment Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the...

  • Interferon
  • China
  • Demand
  • Bayer Schering Pharmaceutical Co., Ltd
  • Changchun ChangSheng Gene Pharmaceutical Co., Ltd.
  • Interferon
  • Interferon Import

This study focuses on China’s Blood Disease Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s...

  • Interferon
  • China
  • Trade
  • Lijun Pharmaceutical Co., Ltd.
  • Shanghai Schering-Plough Pharmaceutical Company, Ltd
  • 4.6 INTERFERON (IFN) BIOSIMILARS MARKET AND FORECAST
  • GLOBAL - FORECAST FOR INTERFERON (IFN) BIOSIMILARS MARKET (MILLION US$), 2016 - 2021

The biosimilars are poised to capture an unprecedented position in the biopharmaceutical industry driven by an increased extent of adoption and growing investment and deal making activity globally. The global biosimilars market is predicted to cross US$ 25 Billion mark by 2020. With the continuous increasing demand for biologics,...

  • Interferon
  • World
  • Market Size
  • Amgen Inc.
  • Biocon Limited

Global Interferon Market & Pipeline Analysis 2015 ##.

  • Biological Therapy
  • Interferon
  • World
  • TYPES OF INTERFERONS
  • 10.4.1. INTERFERON ALFA-2A

INTRODUCTION Characterised by increased utility in chronic diseases and capital intensive manufacturing, the global biopharmaceutical market is expanding robustly. As the demand for biologics is increasing continuously, manufacturers are on the lookout for novel strategies that will help them attain maximum returns on investment.Derived...

  • Interferon
  • North America
  • United States
  • Market Size
  • Sandoz Inc.
  • BIOSIMILARS MARKET FOR INTERFERONS, BY TYPE, 2016-2023 (USD MILLION)
  • ROA: BIOSIMILARS MARKET FOR INTERFERONS, BY TYPE, 2016-2023 (USD MILLION)

The global biosimilars market projected to grow at a CAGR of 31.7% during the forecast period. The biosimilars market is expected to reach USD 23.63 billion by 2023 from USD 5.95 billion in 2018, at a CAGR of 31.7%. Factors driving the growth of this market include increasing demand for biosimilar drugs due to their cost-effectiveness,...

  • Interferon
  • Monoclonal Antibody
  • North America
  • United States
  • Market Size
  • CytoPharm, Inc. to launch ABI's low dose oral interferon for animal diseases in China and Taiwan in March.
  • Section 2 - Company Analysis Amarillo Biosciences Inc - Business Description

Amarillo Biosciences Inc (AMAR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations.The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and...

  • Interferon
  • United States
  • World
  • Company Financials
  • Amarillo Biosciences, Inc.

MARKET ##.

  • Biological Therapy
  • Interferon
  • APAC
  • World
  • Company Sales
  • INTERFERON BETA-1B - DRUG PROFILE
  • INTERFERON BETA-1B - DRUG PROFILE

Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H2 2016, provides an overview of the Relapsing Remitting Multiple Sclerosis (RRMS) (Central...

  • Interferon
  • Monoclonal Antibody
  • Neurological Disorder
  • Therapy
  • AB Science SA
  • Target
  • Clinical Trial profile. 1587 Trial Title

Multiple Sclerosis Global Clinical Trials Review, H1, 2018 Summary GlobalData’s clinical trial report, “Multiple Sclerosis Global Clinical Trials Review, H1, 2018" provides an overview of Multiple Sclerosis clinical trials scenario.This report provides top line data relating to the clinical trials...

  • Clinical Trial
  • Cytokine
  • Interferon
  • Neurological Disorder
  • Biogen Idec Inc.
  • INTERFERON GAMMA - DRUG PROFILE
  • INTERFERON ALFA BIOBETTER - DRUG PROFILE

BioLingus AG - Product Pipeline Review - 2016 Summary Global Markets Direct’s, ‘BioLingus AG - Product Pipeline Review - 2016’, provides an overview of the BioLingus AG’s pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics under development by BioLingus...

  • Interferon
  • World
  • Company Operations
  • Product Initiative
  • BioLingus
  • Clinical Trial profile. 75 Trial Title
  • Clinical Trial profile. 82 Trial Title

Relapsing Multiple Sclerosis (RMS) Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Relapsing Multiple Sclerosis (RMS) Global Clinical Trials Review, H2, 2016" provides an overview of Relapsing Multiple Sclerosis (RMS) clinical trials scenario. This report provides top line data relating...

  • Cytokine Receptor
  • Interferon
  • World
  • Product Initiative
  • Biogen Idec Inc.
  • Clinical Trial profile. 193 Trial Title
  • Clinical Trial profile. 69 Trial Title

Relapsing Remitting Multiple Sclerosis (RRMS) Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Relapsing Remitting Multiple Sclerosis (RRMS) Global Clinical Trials Review, H2, 2016" provides an overview of Relapsing Remitting Multiple Sclerosis (RRMS) clinical trials scenario. This report...

  • Clinical Trial
  • Drug Discovery And Development
  • Interferon
  • World
  • Product Initiative
  • Key Facts
  • Bolder Biotechnology, Inc., Key Facts

Bolder Biotechnology, Inc. - Product Pipeline Review - 2016 Summary Global Markets Direct’s, ‘Bolder Biotechnology, Inc. - Product Pipeline Review - 2016’, provides an overview of the Bolder Biotechnology, Inc.’s pharmaceutical research and development focus. The report provides comprehensive information on the...

  • Growth Hormone
  • Interferon
  • United States
  • Company Operations
  • Bolder BioTechnology, Inc.